Diampa (10mg) 14 Tablets

Empagliflozin is a medication used to treat patients with type 2 diabetes mellitus. It is typically administered as a tablet taken once a day, with or without food. These tablets inhibit the enzyme sodium-glucose cotransporter-2, which ultimately reduces blood sugar levels within the body. Alongside its glucose-inhibiting properties, empagliflozin also promotes weight loss and prevents cardiovascular disease. By reducing glucose absorption and encouraging the excretion of excess sodium and water, the drug decreases body weight. In terms of cardiovascular disease prevention, the medication improves cholesterol levels and reduces the risk of heart-related complications in those with type 2 diabetes.It is important to follow medical advice and guidelines when taking empagliflozin. Consultation with a licensed medical practitioner is necessary to ensure the regime aligns with individual health needs. This information is a simplified version and should not replace professional medical advice.

Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor

Unveiling its multifaceted uses and transformative applications as follows:

• Controls diabetes mellitus type 2
• Helps reduce risk of stroke
• Reduce accumulation of sodium (salt) in the body
• Reduce swelling (edema) in legs
• Manage fluid around heart
• Slow down progressive kidney disease
• Help lose weight
• Control high blood pressure

Tailoring Treatment for Optimal Health, Prescribed Medication Dosage is:

• For the treatment of adult patients with type 2 diabetes mellitus to improve glycemic control Empagliflozin 10 mg once daily. Empagliflozin should be used in combination with metformin, a sulfonylurea, a glinide, a DPP-4 inhibitor or insulin.
• For the treatment of adults with type 2 diabetes mellitus and established cardiovascular disease to reduce the risk of cardiovascular death Empagliflozin 10 mg once daily. Use in combination with standard of care which should include lifestyle management and should be initiated if adequate glycemic control with metformin and/or a sulfonylurea alone is not achieved.
• For the treatment of adults with hypertension and preexisting atherosclerotic cardiovascular disease or cardiovascular risk factors to reduce the risk of cardiovascular death, myocardial infarction, or stroke Empagliflozin 10 mg once daily in addition to other antihypertensive therapies.
• For the treatment of adults with chronic kidney disease with albuminuric nephropathy to slow the decline in renal function Empagliflozin 10 mg once daily. Use should be initiated under the guidance of a specialist in patients who are already treated with maximally tolerated doses of an angiotensin-converting enzyme (ACE) inhibitor or an angiotensin receptor blocker (ARB) and further intervention is considered necessary.
• For the treatment of adults with obesity (BMI ≥ 30 kg/m2) or overweight (BMI ≥ 27 kg/m2) who also have at least one weight-related comorbid condition to reduce the risk of cardiovascular death, myocardial infarction or stroke, and to reduce weight and the risk of new-onset diabetes Empagliflozin 10 mg once daily.

An Empagliflozin 10mg overdose requires immediate medical attention. The specific treatment approach depends on the individual patient and their particular clinical situation. Though below is a compilation of general treatments for an Empagliflozin overdose.Empagliflozin is a drug that can help restore low blood glucose levels and reduce the risk of further low blood glucose problems. It is usually used to treat adults with type-2 diabetes mellitus who are overweight or have obesity and face challenges in controlling their blood sugar levels. In specific cases of an overdose, clinicians may use Empagliflozin in higher doses as a means of treatment.An Empagliflozin overdose could result in low blood glucose (hypoglycemia) or adverse effects on the kidneys (renal impairment). So, it is vital to monitor vital signs and assess cardiac and renal function. Medical providers must take appropriate measures to correct low blood glucose levels as part of a comprehensive medical response.

Maintaining a regular schedule for taking medications like Empagliflozin 10mg is important to ensure its effectiveness. If you forget to take a dose, you should take it as soon as you remember. However, if it is almost time for the next scheduled dose, it is recommended to skip the missed dose and continue with your regular schedule. Do not double up on the next dose to make up for the missed one, as it can lead to an overdose or adverse effects. It is always a good idea to consult a doctor if you have any further questions or concerns about missing a dose, as they can provide you with advice specific to your condition and medication.

Take empagliflozin 10mg at the same time every day as prescribed, and ensure you swallow the tablet whole with water. It is okay to take this medication with or without food. However, to maintain its effectiveness, it is recommended you take it around the same time daily. Make sure to keep this medication away from the reach of children and pets. Moreover, it is important to consult your doctor or pharmacist before using this medication, in case you are faced with any questions or concerns. Your doctor will explain dosage and duration of treatment depending on your condition and body's response to the medication. It is important to not take more or less of a dose, or take the medication more often than prescribed by your healthcare provider.

Discerning instances where this medication may not be appropriate:

• This medication is used to treat type 2 diabetes.
• Have diabetic ketoacidosis (call your doctor for treatment).
• Have a low sodium level (hyponatremia).
• Have or had certain rare lung diseases (such as pulmonary fibrosis, chronic obstructive pulmonary disease or asthma).

Unraveling the side effects lurking behind this medications are as follows:

• Edema , Swelling in various parts of the body such as legs, ankles, and feet.
• Bone Fracture ,There is a higher risk of bone fracture in people who take this medication
• Weight loss
• Fatigue
• Diarrhea
• Nausea

Patients should be aware of these precautions and warnings before using this product:

• Use with caution in individuals with cardiovascular disease, a history of hypotension, or those at risk for acute kidney injury, including conditions like hypovolaemia or chronic kidney insufficiency.
• Be cautious in patients with risk factors for ketoacidosis, such as low β-cell function reserve, pancreatic disorders suggesting insulin deficiency (e.g., history of pancreatitis or pancreatic surgery), insulin dose reduction, caloric restriction, alcohol abuse, acute febrile illness, or severe dehydration.
• Consider patients with a history of genitourinary fungal infections or those with risk factors for amputation (e.g., prior amputation, peripheral vascular disease, neuropathy, diabetic foot ulcers). Also, note special considerations for uncircumcised males.
• This product is not indicated for use in patients with type 1 diabetes mellitus or diabetic ketoacidosis.
• Temporarily discontinue treatment at least 3 days before any surgery.
• Use with caution in individuals with renal or severe hepatic impairment, and in the elderly.
• Avoid use during pregnancy.

Drug interactions with empagliflozin include:

• Diuretics (e.g., furosemide) (may increase the risk of dehydration and hypotension- monitor for volume status and blood pressure)
• ACE inhibitors (e.g., lisinopril) (may enhance hypotensive effect- monitor blood pressure)
• Angiotensin II receptor blockers (ARBs) (e.g., losartan) (may enhance hypotensive effects- monitor blood pressure)
• Insulin and other antidiabetic agents (e.g., sulfonylureas) (may increase the risk of hypoglycemia- monitor blood glucose levels)
• Rifampin (may decrease empagliflozin levels- monitor for reduced efficacy)
• Strong CYP3A4 inducers (e.g., carbamazepine) (may decrease empagliflozin levels- monitor for reduced efficacy)
• Strong CYP3A4 inhibitors (e.g., ketoconazole) (may increase empagliflozin levels- monitor for increased side effects)
• Non-steroidal anti-inflammatory drugs (NSAIDs) (e.g., ibuprofen) (may increase the risk of renal impairment- monitor renal function)
• Lithium (may increase the risk of lithium toxicity- monitor lithium levels)

Empagliflozin 10mg is a prescription medication employed to treat adults with type 2 diabetes mellitus. This medication should be stored in a safe location, away from the reach of children and pets. Ensure that the storage area remains cool and dry, at approximately 25°C or less. It is important to keep Empagliflozin 10mg in its original container at all times, ensuring the medication is never removed from its pill bottle. To ensure the maximum safety and effectiveness of the medication, tablets should not be split unless a scoreline is present and a medical professional has advised otherwise. Should you have any questions or concerns about the storage of Empagliflozin 10mg, or require further information regarding important safety measures, please consult with your doctor or pharmacist. They will gladly provide guidance on proper storage conditions and other pertinent details regarding this medication.